Home › Leucemia mieloide acuta › California › Baldwin Park
Studi clinici su Leucemia mieloide acuta a Baldwin Park, CA
40 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Baldwin Park e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
In reclutamentoFase 2/3
- City of Hope National Medical Center /ID# 279568, Duarte · a 4 mi di distanza
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
In reclutamentoFase 3
- City of Hope, Duarte · a 4 mi di distanza
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
In reclutamentoFase 3
- Clinical Trial Site, Duarte · a 4 mi di distanza
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
In reclutamentoFase 3
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi di distanza
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
In reclutamentoFase 2
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi di distanza
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
In reclutamentoFase 1
- City of Hope National Medical Center, Duarte · a 4 mi di distanza
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
In reclutamentoFase 1/2Volontari sani benvenuti
- City of Hope, Duarte · a 4 mi di distanza
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
In reclutamentoFase 1/2
- City of Hope Comprehensive Cancer Center, Duarte · a 4 mi di distanza
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
In reclutamentoFase 1/2
- City of Hope National Medical Center, Duarte · a 4 mi di distanza
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
Individualized AML Treatment
In reclutamentoStudio osservazionale
- City of Hope Medical Center, Duarte · a 4 mi di distanza
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
In reclutamentoFase 1Volontari sani benvenuti
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
In reclutamentoFase 3
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · a 4 mi di distanza
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- City of Hope, Duarte · a 4 mi di distanza
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
A Study of Revumenib and Mezigdomide in People With Leukemia
In reclutamentoFase 1/2
- City of Hope Cancer Center (Data collection only), Duarte · a 4 mi di distanza
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
In reclutamentoFase 1Volontari sani benvenuti
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
In reclutamentoFase 2
- City of Hope, Duarte · a 4 mi di distanza
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
In reclutamentoFase 2Volontari sani benvenuti
- City of Hope Medical Center, Duarte · a 4 mi di distanza
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
In reclutamentoFase 1
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · a 4 mi di distanza
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
In reclutamentoFase 2
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
In reclutamentoFase 1
- City of Hope - Duarte, Duarte · a 4 mi di distanza
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
In reclutamentoFase 1
- City of Hope Medical Center, Duarte · a 4 mi di distanza
Study of REM-422 in Patients With AML or Higher Risk MDS
In reclutamentoFase 1
- City of Hope, Duarte · a 4 mi di distanza
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
In reclutamentoFase 1
- City of Hope National Medical Center, Duarte · a 4 mi di distanza
Studi su Leucemia mieloide acuta in altre città
- Houston, TX85 studi
- New York City, NY51 studi
- Boston, MA44 studi
- Seattle, WA40 studi
- Columbus, OH35 studi
- Philadelphia, PA34 studi
- Durham, NC33 studi
- Atlanta, GA30 studi
- Tampa, FL29 studi
- Chicago, IL26 studi
- Portland, OR25 studi
- Miami, FL24 studi
Altri studi a Baldwin Park
- Cancro al seno45 studi
- Cancro colorettale38 studi
- Cancro del polmone non a piccole cellule36 studi
- Cancro (tutti i tipi)33 studi
- Cancro alla prostata30 studi
- Cancro metastatico30 studi
- Sindromi mielodisplastiche26 studi
- Cancro ovarico25 studi
- Cancro ai polmoni24 studi
- Mieloma multiplo23 studi
- Cancro dello stomaco22 studi
- Leucemia linfoblastica acuta21 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.